Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.

Here’s what experts know about NARS1 — the condition affecting Marley Mansour, a girl from North Texas — how it’s diagnosed, ...

Findings demonstrate ATYR2810’s anti-tumor activity and increased survival in a model of glioblastoma multiforme (GBM), a ...

An 11-year-old from Rowlett is set to make medical history as the first person in the world to receive treatment for NARS1.

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr” or the "Company”), a clinical stage biotechnology company engaged in the discovery and development of ...

(Juan Figueroa / Staff Photographer) NARS1, short for asparagine-tRNA synthetase, is critical in protein synthesis. Mutations of this gene disrupt the body’s ability to produce proteins ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-cl ...

Furthermore, functional groups are introduced by an orthogonal tRNA/aminoacyl-tRNA synthetase pair recognizing the amber stop codon at position 26, which enabled the click chemistry-based linkage of ...